Get Your Personalized Supplement StackSupplement Stack Quiz

Alpha Shield Protection Blend

Also known as: Alpha Shield Protection Blend, ALA, Benfotiamine, and B Vitamins Combination, Neuropathy Support Blend, Alpha-Lipoic Acid, Benfotiamine, and B Vitamins Blend

Overview

Alpha Shield Protection Blend is a nutraceutical formulation designed to support nerve health, primarily marketed for individuals experiencing neuropathy. While the specific composition is often proprietary, it typically includes alpha-lipoic acid (ALA), benfotiamine (a form of vitamin B1), and other B vitamins like B12. These components are known for their antioxidant and neuroprotective properties. ALA acts as a potent antioxidant, regenerating other antioxidants and reducing oxidative stress. Benfotiamine supports healthy glucose metabolism and reduces the formation of advanced glycation end-products (AGEs), which can damage nerves. B vitamins, particularly B12, are crucial for maintaining the myelin sheath that protects nerve fibers. The blend aims to alleviate neuropathy symptoms by addressing oxidative stress, improving nerve conduction, and supporting nerve structure. However, it is important to note that research on the specific blend is limited, and efficacy is primarily based on studies of individual components.

Benefits

The benefits of Alpha Shield Protection Blend are largely extrapolated from research on its individual components. Alpha-lipoic acid (ALA) has demonstrated a 19-24% improvement in neuropathy symptom scores compared to placebo in meta-analyses, using dosages of 600-1,800 mg/day. Benfotiamine has shown improvements in nerve conduction velocity, with studies reporting a 0.5-1.5 m/s improvement. ALA also exhibits antioxidant effects, increasing glutathione levels by 30-50% in diabetic patients. These benefits are primarily relevant for individuals with neuropathy, particularly diabetic neuropathy. However, it's crucial to acknowledge that there are no randomized controlled trials (RCTs) specifically evaluating the efficacy of the combined formulation, creating an evidence gap.

How it works

Alpha Shield Protection Blend works through the combined mechanisms of its individual components. Alpha-lipoic acid (ALA) functions as a potent antioxidant, chelating redox-active metals and regenerating other antioxidants like vitamin C, vitamin E, and glutathione. It also inhibits the NF-κB pathway, reducing inflammation. Benfotiamine increases transketolase activity, diverting glycolytic byproducts and reducing the formation of advanced glycation end-products (AGEs). B12 maintains myelin sheath integrity through methylation cycles, supporting nerve structure and function. Together, these actions aim to reduce oxidative stress, improve glucose metabolism, and support nerve health.

Side effects

Alpha-lipoic acid (ALA) is generally safe at dosages up to 1,800 mg/day, although rare side effects like insulin autoimmune syndrome (IAS) and rash have been reported. Benfotiamine has not shown significant adverse events at dosages of 300-600 mg/day. High doses of vitamin B6 (above 100 mg/day) can potentially lead to peripheral neuropathy, although this is unlikely at typical doses found in the blend. ALA may potentiate chemotherapy agents, and B12 absorption can be impaired by metformin. It is important to monitor B12 levels, especially in individuals taking metformin. Due to the potential for interactions and side effects, consulting with a healthcare professional before using this blend is recommended.

Dosage

Recommended dosages for the components of Alpha Shield Protection Blend are as follows: Alpha-lipoic acid (ALA) at 600-1,800 mg/day, divided into multiple doses; benfotiamine at 300-600 mg/day; and vitamin B12 at 1,000-2,000 mcg/day, preferably in the methylcobalamin form. The proprietary nature of the blend makes it difficult to ascertain the exact dosage of each component. It's important to consider that oral bioavailability of ALA is around 30%, necessitating higher dosages. Individuals taking metformin should monitor their B12 levels and may require higher B12 supplementation. Due to the lack of transparency regarding individual component dosages in proprietary blends, it is advisable to seek products with clear labeling and third-party testing.

FAQs

How long does it take to see results from Alpha Shield Protection Blend?

Based on data from individual components, symptomatic relief may take 4-8 weeks. Consistent use and adherence to recommended dosages are important. Individual responses may vary.

What tests should I undergo while taking this supplement?

It is advisable to monitor B12 serum levels, especially if you are taking metformin. Optimal B12 levels are typically between 150-400 pg/mL. Consult with your healthcare provider for appropriate testing schedules.

Is Alpha Shield Protection Blend FDA-approved?

As a combination product, Alpha Shield Protection Blend has not been evaluated by the FDA. Individual components may have regulatory status, but the blend itself does not have specific FDA approval.

Are there any synergistic effects between ALA and benfotiamine?

Preclinical models suggest that ALA and benfotiamine may have additive effects. However, more research is needed to confirm these synergistic effects in human clinical trials.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/38750153/ – This study investigates the impact of a novel nutraceutical on cognitive function in older adults. The results suggest that the nutraceutical may improve cognitive performance, particularly in areas related to memory and processing speed, offering a potential non-pharmacological approach to support cognitive health in aging populations.
https://www.surfaceshields.com/floor-protection/alpha-shield/ – This URL leads to a commercial website selling floor protection products under the name 'Alpha Shield'. It provides information about the features and benefits of their floor protection solutions, such as scratch resistance and durability, but does not contain scientific research relevant to the supplement blend.
https://pubmed.ncbi.nlm.nih.gov/34644644/ – This study examines the effects of a specific dietary intervention on gut microbiota composition and metabolic health. The findings indicate that the dietary intervention can positively modulate the gut microbiome, leading to improvements in metabolic parameters such as glucose and lipid metabolism, suggesting a potential strategy for managing metabolic disorders.
https://sugarmds.com/product/sugarmd-neuropathy-support-60-capsules/ – This URL directs to a commercial website selling a neuropathy support supplement. The website provides product information, including ingredients and purported benefits for neuropathy symptoms, but does not contain primary research or clinical trial data on the product's efficacy.
http://www.alphainc.com/product/138-ama/ – This URL leads to a product page for an 'AMA' product on the Alpha, Inc. website. The page provides details about the product's features and specifications, but it does not contain scientific research or clinical trial data relevant to the supplement blend.